First US treatment with Medtronic's heart device:
This article was originally published in Clinica
Executive Summary
Cardiologists have successfully implanted Medtronic's InSync device for treating heart failure, the first implant of the device in the US. The device, designed to synchronise the beating of the right and left side of the of the heart, as well as the upper and lower chambers, uses three transvenous leads to stimulate three chambers of the heart. Stimulation of the left ventricle is achieved via a lead passed through a coronary vein on the surface of the heart and therefore avoids open chest surgery. The InSync device is already available in Europe, said Minneapolis-based Medtronic.